All Categories chevron icon Inpatient Clinical Care chevron icon Pharmacy Solutions chevron icon Purchasing Optimization Analytics

Decision Insights™ Purchasing Optimization Analytics Commentary

Subject Expert
Jackson Tate
Research Director
KLAS Research Director - Jackson Tate
Return to Decisions  Show Filters
Step 13 of

Interview Timeframe

Step 14 of
Within Months: [0 - 24]
24
0
 
Step 12 of
Step 18 of

Comment Filters

Step 15 of
Product
Step 16 of
Category Type

Step 1 of
Step 2 of

Comments Summary    Filtered view:
Interview collection 0 to 24 months

Shows number of comments for Being Replaced Decided/Likely Choice Considered
Step 5 of
Step 3 of
Step 4 of
6

19

to see the full dataset.

If you don't have a login, getting started is easy.

Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Step 6 of

Decision Commentary 
Step 11 of
  Filtered view:
Interview collection 0 to 24 months

Step 10 of
Bluesight CostCheck CostCheck
 

Decided / Likely Choice

Director

We chose CostCheck for ease of use, and we were already live with Bluesight’s KitCheck solution, so...

 or  to see details.

 

Title Goes Here

Manager

Bluesight has been very up front and open about their pricing matrix and their cost structure...

 or  to see details.

 

Title Goes Here

Director

We are considering CostCheck, and everybody likes it to an extent, but the lack of integration with...

 or  to see details.

 

Title Goes Here

Unknown

Bluesight was a leading contender in our decision, but their functionality was very rudimentary, and...

 or  to see details.

QuicksortRx QuicksortRx
 

Title Goes Here

Director

We are considering QuicksortRx, but we really like another vendor who would be a big help to us with...

 or  to see details.

 

Title Goes Here

Manager

We were looking at QuicksortRx and were likely to purchase their product, but another vendor who we...

 or  to see details.

SpendMend Trulla Trulla
 

Title Goes Here

Director

We are considering SpendMend because we really like what they are offering in their ordering...

 or  to see details.

 

Title Goes Here

Unknown

We did a fairly comprehensive look at various vendors and talked to some colleagues around the...

 or  to see details.

 

Title Goes Here

Manager

We were considering using another solution originally, but then SpendMend, who we use for other...

 or  to see details.

 

Title Goes Here

Analyst/Coordinator

What we didn’t like about SpendMend was the cost. They had the highest cost we saw.

 or  to see details.

Verity Solutions Verisave Verisave
 

Title Goes Here

Manager

We looked at Verity Solutions' system, but we chose a different vendor's system.

 or  to see details.

 

Title Goes Here

Director

We are considering Verity Solutions for a short-term engagement to see what they can do if they can...

 or  to see details.






Related ReportsView All Reports
Emerging Technology
KLAS article icon
QuicksortRx 2023
17 February 23    |   Jackson Tate and Jacob Brown
Drug procurement is a large expenditure for health systems, and it is often complex and time consuming to optimize spending. QuicksortRx hopes to reduce this burden with their pharmacy decision support platform that aims to use real-time data analysis to lower pharmacy spend efficiently. This report examines the experiences of customers using the QuicksortRx platform.
First Look
KLAS article icon
Bluesight CostCheck (formerly Kit Check Bluesight Insights) 2023
20 January 23    |   Jackson Tate and Kyle Chilton
The Bluesight CostCheck solution (formerly Kit Check Bluesight Insights) assists hospitals and health systems with making intelligent buying decisions by providing real-time market insights. KLAS reported on the product in May 2021 , when it was Bluesight Insights and there were six unique customers live. The vendor has expanded the product to 44 fully live facilities at 15 unique organization and implemented several upgrades, including improved reporting and prioritized recommendations. This report provides a second look at how the CostCheck customer experience is progressing through the solution’s growth and changes.
Emerging Technology
KLAS article icon
SpendMend Trulla
07 October 22    |   Aurene Wilford and Jackson Tate
Pharmacy is the largest category of non-labor spend in healthcare and is one of the most complex areas of spend across any industry. Annually, there is considerable healthcare expenditure that is exacerbated by gaps in the pharmacy supply chain. Pharmacy buyers have limited tools to assist with ordering, costing health systems millions every year. Additionally, procuring medication at affordable prices is a concern for providers, pharmacies, and patients. This report offers an at-a-glance profile of Trulla, a pharmacy procurement software application aimed at helping pharmacy buyers select the most economic NDCs and suppliers, ultimately improving the drug-purchasing process.


Subject Expert
Jackson Tate
Research Director
KLAS Research Director - Jackson Tate



We use cookies! We use essential and basic aggregated, depersonalized Google Analytics cookies to provide the type of content which our visitors are most interested in.  Cookie Policy    
​